PRLD
$3.50+0.15 (+4.32%)
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing JAK2V617F, a driver mutation product for the treatm...
Recent News
Sana Biotechnology (SANA) Appoints Industry Veteran Brian Piper as New CFO
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the most promising penny stocks under $5 to buy. On February 17, Sana Biotechnology appointed Brian Piper as Executive Vice President and Chief Financial Officer. Brian Piper joined the company with over 25 years of biopharmaceutical experience, most recently serving as CFO of Scorpion Therapeutics and its spin-off, […]
Definitive Healthcare And 2 Other Promising Penny Stocks
As the U.S. stock market edges higher with the S&P 500 reaching new milestones, investors are keenly watching for signals from the Federal Reserve and major tech earnings that could influence future trends. Amidst this backdrop, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for those seeking growth at lower price points. Though considered a niche area, these stocks can shine when backed by solid financial health and fundamentals,...
Retail investors in Prelude Therapeutics Incorporated (NASDAQ:PRLD) are its biggest bettors, and their bets paid off as stock gained 12% last week
Key Insights Prelude Therapeutics' significant retail investors ownership suggests that the key decisions are...
December 2025's Intriguing Stocks Priced Below Estimated Value
As major stock indexes in the United States show mixed performance following two consecutive sessions of losses, investors are keeping a close eye on market movements and economic indicators. In this environment, identifying stocks priced below their estimated value can offer potential opportunities for those looking to capitalize on market inefficiencies.
3 Promising Penny Stocks With A Market Cap Below $400M
As the holiday-shortened week begins, major U.S. stock indexes have dipped, with technology shares leading the decline and precious metals retreating from recent highs. In such a fluctuating market landscape, identifying stocks with potential for growth can be challenging but rewarding. Penny stocks, often associated with smaller or emerging companies, continue to offer intriguing opportunities for investors willing to explore beyond traditional blue-chip options. These stocks can provide...